 NEW YORK, July 12, 2021 GLOBE NEWSWIRE -- Brooklyn ImmunoTherapeutics LLC NYSE American: BTX Brooklyn or the Company, a biopharmaceutical company focused on exploring the role that cytokine and gene editingcell therapy can have in treating patients with cancer, blood disorders, and monogenic diseases, today announced that Chief Executive Officer Howard J. Federoff, M.D., Ph.D., will present a corporate overview at the Access to Giving Virtual Investor Conference being held July 13 15, 2021. 